• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2023 Fiscal Year Research-status Report

Study of clinically over-expressed and chimeric RND multidrug efflux pumps from Acinetobacter baumannii and Pseudomonas aeruginosa

Research Project

Project/Area Number 23K14346
Research InstitutionOsaka University

Principal Investigator

ZWAMA MARTIJN  大阪大学, 産業科学研究所, 特任准教授(常勤) (40827052)

Project Period (FY) 2023-04-01 – 2025-03-31
KeywordsRND / Transporter / Multidrug Resistance / MDR / Efflux Pump
Outline of Annual Research Achievements

One of the leading causes of clinical multidrug-resistant (MDR) bacterial hospital isolates is the over-expression of multidrug efflux pumps belonging to the Resistance-Nodulation-cell Division (RND) protein superfamily. We aimed to understand the roles of efflux pumps in clinical isolates to MDR and also study less-studied clinically relevant pumps. During the first fiscal year of this research project, we started the first cloning of RND-type efflux pumps for this project and created active pumps. The results show interesting, novel findings that are relevant and important to the field of multidrug resistance. The preliminary results were very interesting, and we are currently continuing to investigate the phenotypes to help us understand multidrug resistance caused by the RND-type efflux pumps of P. aeruginosa, E. coli, and A. baumannii. Gene expression analysis was also performed, which gave us detailed information about the resistance factors in the resistant bacteria. In this fiscal year, we were also able to publish three papers, including drafting multiple manuscripts and laying the groundwork for additional research and publications in the near future, likely for the next fiscal year.

Current Status of Research Progress
Current Status of Research Progress

1: Research has progressed more than it was originally planned.

Reason

The research went smoothly because there were no problems with cloning, and experimental results showed interesting preliminary results already.

Strategy for Future Research Activity

Continue with the research as planned and perform experiments based on the positive procedures and results.

Causes of Carryover

Because the cloning and experiments were going very smoothly, we did not need as much Article Costs, which we could spend on other things very useful for the study. Most of the grant was used, about about 20% is carried over to the next fiscal year where the budget is also a lot less, so it will be very usefull.

  • Research Products

    (3 results)

All 2024 2023

All Journal Article (3 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results)

  • [Journal Article] Development of a bacterial release compound assay for prevention and early detection of bacteria-derived diseases2024

    • Author(s)
      S. Yamasaki, N. Koga, T. Hosomi, M. Zwama, C. Jirayupa, T. Yanagida, K. Nishino
    • Journal Title

      Medical Science Digest

      Volume: 50 Pages: 41-43

  • [Journal Article] Comprehensive analysis of the binding site for efflux transporter inhibitors in Pseudomonas aeruginosa2023

    • Author(s)
      Seiji Yamasaki, Martijn Zwama, Naoki Koga, Keisuke Sakurai, Ryosuke Nakashima, Akihito Yamaguchi, Kunihiko Nishino
    • Journal Title

      Bio Clinica

      Volume: 38 Pages: 74-78

  • [Journal Article] Drug resistance and physiological roles of RND multidrug efflux pumps in Salmonella enterica, Escherichia coli and Pseudomonas aeruginosa2023

    • Author(s)
      Yamasaki Seiji、Zwama Martijn、Yoneda Tomohiro、Hayashi-Nishino Mitsuko、Nishino Kunihiko
    • Journal Title

      Microbiology

      Volume: 169 Pages: 001322

    • DOI

      10.1099/mic.0.001322

    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2024-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi